John Overdeck’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,000
Closed -$548K 4192
2021
Q4
$548K Buy
6,000
+4,000
+200% +$429K ﹤0.01% 3164
2021
Q3
$257K Sell
2,000
-3,300
-62% -$462K ﹤0.01% 3776
2021
Q2
$808K Sell
5,300
-7,400
-58% -$975K ﹤0.01% 2668
2021
Q1
$1.34M Buy
12,700
+4,500
+55% +$451K ﹤0.01% 2051
2020
Q4
$650K Buy
8,200
+3,400
+71% +$249K ﹤0.01% 2317
2020
Q3
$271K Buy
+4,800
New +$259K ﹤0.01% 2639
2020
Q2
Sell
-9,400
Closed -$303K 3491
2020
Q1
$303K Sell
9,400
-1,300
-12% -$43.8K ﹤0.01% 2297
2019
Q4
$376K Buy
+10,700
New +$353K ﹤0.01% 3016

Other funds holding STAA

John Overdeck's STAA Position: Q2 2026 in Review

John Overdeck reduced its STAAR Surgical (STAA) stake by 80% in Q2 2026, selling an estimated $12.5M and leaving 110,288 shares worth $3.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2571.

John Overdeck first reported a position in STAA in Q2 2013 and has held it in 37 quarters since. The position peaked at $17.2M in Q2 2023. 199 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • John Overdeck held 110,288 shares of STAAR Surgical worth $3.16M as of Q2 2026.
  • John Overdeck sold 449,298 STAAR Surgical shares in Q2 2026, an estimated $12.5M.
  • STAAR Surgical made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2571 holding.
  • John Overdeck first reported a position in STAAR Surgical in Q2 2013 and has held it in 37 quarters since.
  • John Overdeck's STAAR Surgical position peaked at $17.2M in Q2 2023.
  • 199 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.